The Cuban partner is Bio Cuba Farma, the leading Cuban State Enterprise with 38 subsidiaries, including 16 production sites. The Hubei center will be built in two phases on 100 acres (~4000 m2) with an investment of 250 mill Yuan, and eventually produce 500 kg of drug materials under cGMP standards.

China Bio news release, Nov. 11, 2014